Cite
HARVARD Citation
Sho, M. et al. (2013). Pathological and clinical impact of neoadjuvant chemoradiotherapy using full‐dose gemcitabine and concurrent radiation for resectable pancreatic cancer. Journal of hepato-biliary-pancreatic sciences. 20 (2), pp. 197-205. [Online].